Professional Summary
Education & Certifications
- Board Certification: American Board of Radiology, Diagnostic Radiology (2009)
- Fellowship: UCLA Radiology Fellowships (2006) CA
- Residency: Royal Liverpool Hospital (2005) United Kingdom
-
- Residency: Princess Royal Hospital Medicine Residency (1999) United Kingdom
- Internship: Stanley Medical College (1995) India
- Medical Education: Stanley Medical College (1994) India
Publications
-
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial
Hochman, J. S., Reynolds, H. R., Bangalore, S., O'Brien, S. M., Alexander, K. P., Senior, R., … Jeffries, N. (2019). Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial. JAMA CARDIOLOGY, 4(3), 273–86. -
Management of Coronary Disease in Patients with Advanced Kidney Disease.
Bangalore, S., Maron, D. J., O'Brien, S. M., Fleg, J. L., Kretov, E. I., Briguori, C., … Hochman, J. S. (2020). Management of Coronary Disease in Patients with Advanced Kidney Disease. The New England Journal of Medicine. -
Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease.
Spertus, J. A., Jones, P. G., Maron, D. J., Mark, D. B., O'Brien, S. M., Fleg, J. L., … Bangalore, S. (2020). Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease. The New England Journal of Medicine. -
-
Initial Invasive or Conservative Strategy for Stable Coronary Disease.
Maron, D. J., Hochman, J. S., Reynolds, H. R., Bangalore, S., O'Brien, S. M., Boden, W. E., … Rosenberg, Y. (2020). Initial Invasive or Conservative Strategy for Stable Coronary Disease. The New England Journal of Medicine. -
Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease.
Spertus, J. A., Jones, P. G., Maron, D. J., O'Brien, S. M., Reynolds, H. R., Rosenberg, Y., … Mark, D. B. (2020). Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease. The New England Journal of Medicine. -
Constrictive Pericarditis Revealing Rare Case of ALH Amyloidosis With Underlying Lymphoplasmacytic Lymphoma (Waldenstrom Macroglobulinemia).
Ho, V. V., O'Sullivan, J. W., Collins, W. J., Ozdalga, E., Bell, C. F., Shah, N. D., … Witteles, R. M. (2022). Constrictive Pericarditis Revealing Rare Case of ALH Amyloidosis With Underlying Lymphoplasmacytic Lymphoma (Waldenstrom Macroglobulinemia). JACC. Case Reports, 4(5), 271–275. -
Heart transplantation with concomitant reoperative total aortic arch replacement in a patient with end-stage heart failure and chronic aortic arch dissection.
Kasinpila, P., Krishnam, M., & Woo, Y. J. (2022). Heart transplantation with concomitant reoperative total aortic arch replacement in a patient with end-stage heart failure and chronic aortic arch dissection. JTCVS Techniques, 15, 144–146. -
Intramyocardial hemorrhage drives fatty degeneration of infarcted myocardium.
Cokic, I., Chan, S. F., Guan, X., Nair, A. R., Yang, H.-J., Liu, T., … Dharmakumar, R. (2022). Intramyocardial hemorrhage drives fatty degeneration of infarcted myocardium. Nature Communications, 13(1), 6394. -
The utility of time resolved magnetic resonance angiography in differentiating vascular malformations.
Bista, B., Yousra, A., Bosemani, T., Gedeon, D., Bista, A., Shrestha, S., & Krishnam, M. (2023). The utility of time resolved magnetic resonance angiography in differentiating vascular malformations. Clinical Imaging, 101, 150–155. -
The 2022 FASEB Virtual Catalyst Conference on the Cardiac Interatrial Septum and Stroke Risk, December 7, 2022.
Schilling, J., Lin, J. P., Mankad, S. V., Krishnam, M. S., Ning, M. M., Patel, P. M., … Fisher, M. J. (2023). The 2022 FASEB Virtual Catalyst Conference on the Cardiac Interatrial Septum and Stroke Risk, December 7, 2022. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, 37(9), e23122. -
Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study.
Kodali, S., Hahn, R. T., Makkar, R., Makar, M., Davidson, C. J., Puthumana, J. J., … Windecker, S. (2023). Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study. European Heart Journal. -
Non-electrocardiogram-gated, free-breathing, off-resonance reduced, high-resolution, whole-heart myocardial T2 * mapping at 3 T within 5 min.
Guan, X., Yang, H.-J. J., Zhang, X., Wang, N., Han, H., Tang, R., … Dharmakumar, R. (2024). Non-electrocardiogram-gated, free-breathing, off-resonance reduced, high-resolution, whole-heart myocardial T2 * mapping at 3 T within 5 min. Magnetic Resonance in Medicine. -
Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial.
Reynolds, H. R., Cyr, D. D., Merz, C. N., Shaw, L. J., Chaitman, B. R., Boden, W. E., … Hochman, J. S. (2024). Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial. Journal of the American Heart Association, e029850. -
Microvascular Obstruction and Intramyocardial Hemorrhage in Reperfused Myocardial Infarctions: Pathophysiology and Clinical Insights From Imaging.
Vora, K. P., Kumar, A., Krishnam, M. S., Prato, F. S., Raman, S. V., & Dharmakumar, R. (2024). Microvascular Obstruction and Intramyocardial Hemorrhage in Reperfused Myocardial Infarctions: Pathophysiology and Clinical Insights From Imaging. JACC. Cardiovascular Imaging. -
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial.
Pracon, R., Spertus, J. A., Broderick, S., Bangalore, S., Rockhold, F. W., Ruzyllo, W., … Maron, D. J. (2024). Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial. Circulation. Cardiovascular Interventions, e013435. -
Wideband radiofrequency pulse sequence for evaluation of myocardial scar in patients with cardiac implantable devices
Shah, N. D., Krishnam, M., Venkatesh, B. A., Khan, F., Smith, M., Jones, D. R., … Yang, P. C. (2024). Wideband radiofrequency pulse sequence for evaluation of myocardial scar in patients with cardiac implantable devices. FRONTIERS IN RADIOLOGY, 4, 1327406. -
Myocardial Blood Flow Quantification Using Stress Cardiac Magnetic Resonance Improves Detection of Coronary Artery Disease.
Wang, S., Kim, P., Wang, H., Ng, M.-Y. Y., Arai, A. E., Singh, A., … Patel, A. R. (2024). Myocardial Blood Flow Quantification Using Stress Cardiac Magnetic Resonance Improves Detection of Coronary Artery Disease. JACC. Cardiovascular Imaging. -
Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial.
Reynolds, H. R., Page, C. B., Shaw, L. J., Berman, D. S., Chaitman, B. R., Picard, M. H., … Hochman, J. S. (2024). Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial. Circulation. Cardiovascular Interventions, 17(12), e013743. -
Transcatheter Aortic Valve Replacement in Patients With Interventricular Membranous Septal Aneurysms.
Theriault-Lauzier, P., Dawson, L. P., Wong, C. C., Sharma, R. P., Fearon, W. F., Kang, G., … Yeung, A. C. (2025). Transcatheter Aortic Valve Replacement in Patients With Interventricular Membranous Septal Aneurysms. JACC. Case Reports, 30(1), 102715.
-
Initial Invasive or Conservative Strategy for Stable Coronary Disease.
Clinical Trials
Clinical trials are ÌÇÐÄ´«Ã½ studies that evaluate a new medical approach, device, drug, or other treatment. As a ÌÇÐÄ´«Ã½ patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Practice Locations
SHC- Radiology (300P) Stanford, CA
Stanford, CAImportant Information about Our Organizations and Physician Affiliation
ÌÇÐÄ´«Ã½, ÌÇÐÄ´«Ã½ Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by ÌÇÐÄ´«Ã½, ÌÇÐÄ´«Ã½ Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of ÌÇÐÄ´«Ã½, ÌÇÐÄ´«Ã½ Tri- Valley, or Stanford Medicine Partners. ÌÇÐÄ´«Ã½, ÌÇÐÄ´«Ã½ Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Referring Physicians
PHYSICIAN HELPLINE
Phone:Ìý1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
ÌÇÐÄ´«Ã½ provides comprehensive services toÌýreferÌýandÌýtrack patients, as well as the latest information and news for physicians and office staff.ÌýFor help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
Ìý
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records